MinorTrial status changed: Recruiting → Enrolling by Invitation
Site details revised
NotableRecruitment openedShow 5 more changesShow less
Eligibility criteria expanded, about 37 words
Start date changed from estimate of Aug 1, 2026 to Sep 15, 2026
Secondary endpoints: details revised at 16 of 16 entries
Study description expanded, about 6 words
Site details revised
NotableEligibility criteria expanded, about 22 words
Collaborators expanded, about 6 words
v4
NotableStart date: May 1, 2026 to Aug 1, 2026v3
NotablePrimary endpoint(s) modified
Secondary endpoints revised (16)
Study description expanded, about 1 word
v2
Study First Submitted
Notable: the plan changed
Minor: routine updates
Endpoints
Primary
Treatment group differences in change from Baseline to 1-week Post-Treatment on Category Fluency
Timeframe: Outcome measures will be assessed as change over a period of 6 weeks: Change from baseline to 1-week Post-Treatment
Treatment group differences in change from Baseline to 2-months Post-Treatment on Category Fluency
Timeframe: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
Treatment group differences in change from Baseline to 1-week Post-Treatment on Phonemic Fluency
Timeframe: Outcome measures will be assessed as change over a period of 6 weeks: Change from baseline to 1-week Post-Treatment
Treatment group differences in change from Baseline to 2-months Post-Treatment on Phonemic Fluency
Timeframe: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-months Post-Treatment
Secondary (16)
Treatment group differences in change from Baseline to 1-week Post-treatment on Speaking Rate during overt reading
Treatment group differences in change from Baseline to 2-months Post-Treatment on Speaking Rate during overt reading
Treatment group differences in change from Baseline to 1-week Post-treatment on Speaking Rate during self-generated speech
Treatment group differences in change from Baseline to 2-months Post-Treatment on Speaking Rate during self-generated speech
Treatment group differences in change from Baseline to 1-week Post-treatment on Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale Part III score.
Show 11 moreShow less
Treatment group differences in change from Baseline to 2-month Post-treatment on Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale Part III score.
Treatment group differences in change from Baseline to 1-week Post-treatment on Speaking Rhythm during overt reading
Treatment group differences in change from Baseline to 2-months Post-Treatment on Speaking Rhythm during overt reading
Treatment group differences in change from Baseline to 1-week Post-treatment on Speaking Rhythm during self-generated speech
Treatment group differences in change from Baseline to 2-months Post-Treatment on Speaking Rhythm during self-generated speech
Treatment group differences in change from Baseline to 1-week Post-treatment on Speaking Pause Time during overt reading
Treatment group differences in change from Baseline to 2-months Post-Treatment on Speaking Pause Time during overt reading
Treatment group differences in change from Baseline to 1-week Post-treatment on Speaking Pause Time during self-generated speech
Treatment group differences in change from Baseline to 2-months Post-Treatment on Speaking Pause Time during self-generated speech
Treatment group differences in change from Baseline to 1-week Post-treatment on Freezing of Gate during the timed up and go task
Treatment group differences in change from Baseline to 2-month Post-treatment on Freezing of Gate during the timed up and go task
Arms and interventions
Transcranial direct current stimulationExperimental
Transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. Stimulation will consist of 1 milliamp stimulation, with anodal stimulation delivered at electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, then remain at 1 milliamp of stimulation over 20 minutes, and finally ramping down at to 0 milliamps over 60 seconds. Other Names: tDCS 1 milliamp tDCS High definition tDCS High definition transcranial direct current stimulator, Neuroelectrics Starstim tES, SN E20200930-10
Sham transcranial direct current stimulationSham comparator
Sham transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. The sham setup will consist of anodal electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, ramp down to 0 milliamps over 60 seconds and then be left off for 20 minutes.
Devices: transcranial direct current stimulation, Sham transcranial direct current stimulation
Sites
1 site in 1 country
Callier Clinical Center, The University of Texas at DallasRichardson, Texas, United States